Researchers sought to determine whether lung function could influence outcomes in patients with hematological malignancies undergoing autologous hematopoietic stem cell transplantation.
Asthma control as measured by AIRQ may predict 12-month HRQoL, according to research reported at the 2021 ACAAI Annual Scientific Meeting.
A post-hoc analysis of LAVOLTA I and II trials assessed effectiveness of lebrikizumab in patients with uncontrolled asthma and high baseline eosinophils.
A retrospective review presented at ACAAI 2021 assessed median cumulative corticosteroid exposure before and after initiation of biologic therapy in AERD.
An analysis of NAVIGATOR trial data on tezepelumab use assessed patient-reported outcomes related to asthma control, symptoms, and HRQoL.
To address the void in data on ventilation trends among children with asthma, investigators analyzed data from the largest US all-payer database.
Researchers conducted pooled analysis of the COUGH-1 and COUGH-2 phase 3 trials of gefapixant for treating refractory/unexplained chronic cough.
Researchers sought to determine whether patients with cancer who were hospitalized with COVID-19 would have a higher mortality rate.
Researcher sought to determine the risk of developing VTE in patients with and without COVID-19 who were hospitalized.
Findings from a retrospective chart review showed a need to carefully monitor inflammatory biomarkers and anticoagulant dosage in patients with severe COVID-19.
